 |
南京科佰生物科技有限公司
主營(yíng)產(chǎn)品： atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫(kù)購(gòu)買 |
會(huì)員.png)
10
聯(lián)系電話
|
南京科佰生物科技有限公司
主營(yíng)產(chǎn)品： atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫(kù)購(gòu)買 |
聯(lián)系電話
| 參考價(jià) | 面議 |
更新時(shí)間：2022-09-06 10:12:27瀏覽次數(shù)：998
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 1ug+1ug |
|---|---|---|---|
| 貨號(hào) | CBP80001-9 | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
| CBP80001-9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| I. Background | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
計(jì)算數(shù)據(jù)下載：
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
